Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States-Reference-Cited by-同舟云学术

Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States

Published:2024-02-01 Issue:2 Volume:38 Page:61-69
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

McCrimmon Tara¹,Collins Lauren F.²,Perez-Brumer Amaya³,Bazzi Angela R.⁴,Shaffer Victoria A.⁵,Kerrigan Deanna⁶,Alcaide Maria L.⁷,Philbin Morgan M.⁸^ORCID

Affiliation:

1. Department of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA.

2. Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

3. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

4. Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California, USA.

5. Department of Psychological Sciences, University of Missouri, Columbia, Missouri, USA.

6. Department of Prevention and Community Health, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.

7. Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.

8. Division of Vulnerable Populations, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/apc.2023.0248

Reference36 articles.

1. Implementation challenges for long-acting antivirals as treatment

2. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

3. Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV

4. Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials

5. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system;Implementation Science Communications;2024-08-29

2. “I Feel Like I Don’t Even Have HIV Anymore”—Facilitators, Barriers, and Experience regarding Use of Long-Acting Injectable Antiretroviral Therapy Among Persons with HIV in North Carolina;AIDS Patient Care and STDs;2024-07-01

3. Perspectives Among Health Care Providers and People with HIV on the Implementation of Long-Acting Injectable Cabotegravir/Rilpivirine for Antiretroviral Therapy in Florida;AIDS Patient Care and STDs;2024-06-01

4. Incidence of Sexually Transmitted Infections in Youth with HIV During Pre-COVID and COVID Era;AIDS Patient Care and STDs;2024-06-01

5. Likelihood of trying long-acting injectable antiretroviral therapy (LAI ART) among women with HIV in nine sites across the United States;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-12